NCT05837806
- Conditions
- Neoadjuvant Immunotherapy
- Locations
-
- The Second Hospital of Tianjin Medical University Tianjin, China
Clinical trial condition
Neoadjuvant Immunotherapy
Explore clinical trials studying Neoadjuvant Immunotherapy. Study availability and eligibility vary by location and protocol.
13 public trials
6 recruiting studies
Neoadjuvant Immunotherapy trial results
NCT07387198
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +20 more
- Locations
-
- Nationales Centrum für Tumorerkrankungen Heidelberg, Baden-Wurttemberg, Germany
- Universitätsklinikum Mannheim Mannheim, Baden-Wurttemberg, Germany
- Universitätsklinikum Tübingen Tübingen, Baden-Wurttemberg, Germany
- Universitätsklinikum Regensburg Regensburg, Bavaria, Germany
NCT06926179
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
- Locations
-
- Peking University Cancer Hospital & Institute Beijing, Beijing Municipality, China
- Peking University Third Hospital Beijing, Beijing Municipality, China
- Inner Mongolia Hospital of Peking University Cancer Hospital Hohhot, Inner Mongolia, China
- The Third Affliated Hospital of Kunming Medical University Kunming, Yunnan, China
NCT06714708
- Conditions
- Low Dose Radiotherapy, NSCLC, Neoadjuvant Immunotherapy, +1 more
- Locations
-
- Anhui Provincial Cancer Hospital Hefei, Anhui, China
NCT06623487
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
- Locations
-
- Ruijin Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China
NCT06209294
- Conditions
- Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
Enrolling by Invitation
Comparison of the Effect of Surgical Resection Based on Lesion Extent Before and After Neoadjuvant Therapy in Patients With Stage II-IIIB Non-Small Cell Lung Cancer: A Single-Center, Real-World, Open-Label Study
NCT07373899
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
- Locations
-
- Cancer Hospital, Chinese Academy of Medical Sciences Beijing, Chaoyang, China
Not Yet Recruiting
Yang et al. Anti-PD-1/CTLA-4 Dual Immunotherapy for LARC
NCT07596290
- Conditions
- Locally Advanced Rectal Adenocarcinoma, Neoadjuvant Chemoradiation, Neoadjuvant Immunotherapy
- Locations
-
Not specified
NCT07515469
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +11 more
- Locations
-
Not specified
Not Yet Recruiting
Neoadjuvant SBRT and Tislelizumab (Immunotherapy) Plus Anlotinib for Resectable EGFR Wild-type NSCLC
NCT07231575
- Conditions
- Chemo-free Therapy, NSCLC, Neoadjuvant Immunotherapy
- Locations
-
Not specified